Cetera Investment Advisers
TMCI icon

Cetera Investment Advisers’s Treace Medical Concepts TMCI Stock Holding History

Cetera Investment Advisers’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.1K Sell
17,351
-51
-0.3% -$140 ﹤0.01% 4726
2026
Q1 		$23.3K Buy
+17,402
New +$34.7K ﹤0.01% 4649
2024
Q3 		– Sell
-13,999
Closed -$93.1K – 3902
2024
Q2 		$93.1K Buy
+13,999
New +$113K ﹤0.01% 3520

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cetera Investment Advisers's TMCI Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Treace Medical Concepts (TMCI) stake by 0.29% in Q2 2026, selling an estimated $140 and leaving 17,351 shares worth $69.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4726.

Cetera Investment Advisers first reported a position in TMCI in Q2 2024 and has held it in 3 quarters since. The position peaked at $93.1K in Q2 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Cetera Investment Advisers held 17,351 shares of Treace Medical Concepts worth $69.1K as of Q2 2026.
  • Cetera Investment Advisers sold 51 Treace Medical Concepts shares in Q2 2026, an estimated $140.
  • Treace Medical Concepts made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4726 holding.
  • Cetera Investment Advisers first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Treace Medical Concepts position peaked at $93.1K in Q2 2024.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.